Eli Lilly (LLY) Says FDA Requests Additional Data on Obesity Pill [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
On April 15, 2026, Eli Lilly and Company (NYSE:LLY) disclosed that the U.S. FDA had requested additional data related to potential liver injury associated with its newly approved obesity pill, along with post-marketing studies on cardiovascular risks and gastric emptying, according to a Reuters report. The agency also required a lactation study as part of its ongoing safety monitoring under the drug's priority review approval. A Lilly spokesperson said there were no indications of liver damage in late-stage trials, adding that “The FDA approved Foundayo based on its review of data from the ATTAIN clinical program,” with post-approval requirements consistent with standard safety evaluation practices. On April 12, 2026, Lilly reported topline results from the Phase 3 BRUIN CLL-322 trial evaluating Jaypirca, a non-covalent Bruton tyrosine kinase inhibitor, in combination with venetoclax and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphoc
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- 2 Millionaire-Maker Stocks to Hold for the Next 10 Years [Yahoo! Finance]Yahoo! Finance
- Foundayo Trial Results Recast Eli Lilly Story On GLP1 Safety And Growth [Yahoo! Finance]Yahoo! Finance
- This Drug Stock Has Crushed the S&P 500 Over the Last Decade [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- This Drug Stock Has Crushed the S&P 500 Over the Last Decade [Yahoo! Finance]Yahoo! Finance
- Better Long-Term Buy: Eli Lilly or Viking Therapeutics? [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form DEFA14A
- 3/20/26 - Form DEF
- LLY's page on the SEC website